Printer Friendly

Articles from US Pharmaceuticals (November 4, 2019)

1-25 out of 25 article(s)
Title Author Type Words
Abbot Laboratories (NYSE: ABT). 2101
Abbvie (NYSE: ABBV) - RINVOQ[TM] (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis -- 31/10/2019. Report 940
Abbvie (NYSE: ABBV). 6114
AmerisourceBergen Corporation (NYSE: ABC). 3769
Amgen (NASDAQ:AMGN) - Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China -- 31/10/2019. 836
Amgen (NASDAQ:AMGN). 2911
AstraZeneca (NYSE: AZN) - AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia -- 30/10/2019. 288
AstraZeneca (NYSE: AZN). 16170
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) (NYSE: BHC). 3957
Baxter International (NYSE: BAX). 2140
Bristol-Myers Squibb (NYSE: BMY). 1776
Eli Lilly & Company (NYSE: LLY). 4062
Genentech (SIX: RO, ROG; OTCQX: RHHBY) - FDA Accepts Genentech's Biologics License Application for Satralizumab for Neuromyelitis Optica Spectrum Disorder -- 29/10/2019. 629
GlaxoSmithKline (LSE: GSK). 16581
Johnson & Johnson (NYSE: JNJ) - Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC) -- 31/10/2019. 1312
Johnson & Johnson (NYSE: JNJ). 815
McKesson Corporation (NYSE: MCK). 3111
Merck & Co. (NYSE: MRK). 3149
Novartis (NYSE: NVS). 3991
Perrigo Company Plc (NYSE: PRGO). 2239
Pfizer Inc (NYSE: PFE). 12315
Regeneron (NASDAQ:REGN) - Dupixent[R] (Dupilumab) Now Approved In European Union For Severe Chronic Rhinosinusitis With Nasal Polyposis -- 29/10/2019. 887
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). 1683
Sanofi (NYSE: SNY). 6940
Teva (NYSE: TEVA). 3968

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters